- Alzheimer's Association Statement – WASHINGTON, March 14, 2012 /PRNewswire-USNewswire/ — During a conference call meeting today among members of the Advisory Council on Alzheimer's Research, Care, and Services and Health and Human Services (HHS) officials, a robust discussion…
Read more:
... continue reading
US Health Authorities have set 2025 as the deadline for coming up with an effective Alzheimer's disease treatment. Some would say this is over-ambitious, because there is no current cure for the disease; and none in the pipeline either. The Alzheimer's Association informs that during the second meeting of the ... continue reading
The U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs Advisory Committee did not recommend approval of florbetapir (Amyvid, Lilly/Avid) injection for imaging amyloid plaques based on the currently available data. At the same time, the committee did vote to recommend approval of florbetapir conditional on development ... continue reading